These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21914024)

  • 1. Cardiac resynchronization therapy: do women benefit more than men?
    Xu YZ; Friedman PA; Webster T; Brooke K; Hodge DO; Wiste HJ; Hua W; Zhang S; Hayes DL; Cha YM
    J Cardiovasc Electrophysiol; 2012 Feb; 23(2):172-8. PubMed ID: 21914024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
    Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of cardiac resynchronization therapy in the elderly.
    Killu AM; Wu JH; Friedman PA; Shen WK; Webster TL; Brooke KL; Hodge DO; Wiste HJ; Cha YM
    Pacing Clin Electrophysiol; 2013 Jun; 36(6):664-72. PubMed ID: 23252710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
    Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of age and gender on cardiac resynchronization therapy outcome.
    Zardkoohi O; Nandigam V; Murray L; Heist EK; Mela T; Orencole M; Ruskin JN; Singh JP
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1344-8. PubMed ID: 17976097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European CRT Survey: 1 year (9-15 months) follow-up results.
    Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
    Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy.
    Kirubakaran S; Ladwiniec A; Arujuna A; Ginks M; McPhail M; Bostock J; Carr-White G; Rinaldi CA
    Int J Clin Pract; 2011 Mar; 65(3):281-8. PubMed ID: 21314865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of CRT-PM versus CRT-D recipients.
    Stabile G; Solimene F; Bertaglia E; La Rocca V; Accogli M; Scaccia A; Marrazzo N; Zoppo F; Turco P; Iuliano A; Shopova G; Ciardiello C; De Simone A
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S141-5. PubMed ID: 19250079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and outcomes of "super-response" to cardiac resynchronization therapy.
    Killu AM; Grupper A; Friedman PA; Powell BD; Asirvatham SJ; Espinosa RE; Luria D; Rozen G; Buber J; Lee YH; Webster T; Brooke KL; Hodge DO; Wiste HJ; Glikson M; Cha YM
    J Card Fail; 2014 Jun; 20(6):379-86. PubMed ID: 24632340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.
    Dong YX; Powell BD; Asirvatham SJ; Friedman PA; Rea RF; Webster TL; Brooke KL; Hodge DO; Wiste HJ; Yang YZ; Hayes DL; Cha YM
    Europace; 2012 Aug; 14(8):1139-47. PubMed ID: 22467754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.
    Iler MA; Hu T; Ayyagari S; Callahan TD; Civello KC; Thal SG; Wilkoff BL; Chung MK
    Am J Cardiol; 2008 Feb; 101(3):359-63. PubMed ID: 18237600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women have better long-term prognosis than men after cardiac resynchronization therapy.
    Zabarovskaja S; Gadler F; Braunschweig F; Ståhlberg M; Hörnsten J; Linde C; Lund LH
    Europace; 2012 Aug; 14(8):1148-55. PubMed ID: 22399204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac resynchronization therapy in women].
    Lunati M; Landolina M; Cipriani M; Rordorf R; Bisetti S; Campo C; Ghio S; Frigerio M
    G Ital Cardiol (Rome); 2012 May; 13(5 Suppl 1):31S-34S. PubMed ID: 23678532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effects of cardiac resynchronization therapy in non-ambulatory NYHA IV heart failure patients.
    Theodorakis G; Katsikis A; Livanis E; Kostopoulou A; Adamopoulos S; Tsiapras D; Voudris V
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1553-60. PubMed ID: 21913946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.